Abstract 3018: Identifying and characterizing subpopulation of exosomes to provide the foundation for a novel exosome-based cancer diagnostic platformTraci Pawlowski, Christine Kuslich, David Spetzler et al.|Cancer Research|2010Cited by 0
Identification and characterization of exosome subpopulations to provide the foundation for a novel exosome-based cancer diagnostic platformTraci Pawlowski, Christine Kuslich, David Spetzler et al.|Unknown|2000Cited by 0
Abstract 3246: Important differences between exosome biosignatures from prostate cancer patient plasma samples and prostate cancer cell linesTeresa L. Tinder, Christine Kuslich, David Spetzler et al.|Cancer Research|2010Cited by 0
Use of transcriptomic signatures of <i>RAD51</i> and <i>GATA6</i> to predict real-world overall survival with platinum therapy in <i>BRCA/PALB2</i> wild-type metastatic pancreatic cancer.Binbin Zheng-Lin, Tanios S. Bekaii-Saab, Ellen Jaeger et al.|Journal of Clinical Oncology|2026Cited by 0
Molecular characterization of resected non-metastatic pancreatic cancer (PC) based on <i>KRAS</i> status.Angelo Pirozzi, Tanios S. Bekaii-Saab, Ellen Jaeger et al.|Journal of Clinical Oncology|2026Cited by 0